NCT05627583

Brief Summary

The design of this project is a longitudinal trial in patients with Anorexia Nervosa (AN) during in-hospital rehabilitation. Τhe structure of the study, the questionnaires and data protection policy prepared exclusively for our study, have been reviewed and standardised at Institutional Review Boards (Ethics Committees, IRBs,) in Harokopio University of Athens (HUA), Eginition Hospital (EH), Attiko Hospital (AH) and Sismanoglio Hospital (SG). AN is a psychiatric disorder followed by a psychopathologic concerning of body image and very low body weight due to extreme self-starvation. The exact pathogenesis of AN remains unknown with neurobiological, gastrointestinal, neuroendocrinological, immunological, and genetic factors suspected to be implicated. Furthermore, many metabolic traits, biochemical, biological or/and anthropometrical, are manifested during the maintaining effort of patients to achieve lower body weight. Self-inflicted starvation is the primary and essential causation of the pathological outcomes of the disorder. These outcomes involve all biological systems and organs. The role of the immune system in AN is critical as levels of pro-inflammatory cytokines are increased and the immune system is dysregulated. Other contributors to AN pathogenesis have been proposed, such as increased oxidative stress, dysbiosis of the gut microbiota and altered metabolomic profiles. Treatment options for patients with AN constitutes outpatient and inpatient care accordingly with the severity of the disorder. So far, no biomarker has been strongly proposed as an indicator of the disorder's severity or for assessing the progression of the treatment. The purpose of this study is to assess and monitor the nutritional rehabilitation of patients with AN during hospitalization treatment. Throughout the treatment's course, nutrition and feeding process, vital signs, psychopathology and biological samples will be gathered and statistical analysis of these data is expected to reveal potential biomarker/s for monitoring the progression of recovery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 8, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

November 25, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 24, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 24, 2023

Completed
Last Updated

May 20, 2025

Status Verified

October 1, 2024

Enrollment Period

1.1 years

First QC Date

November 8, 2022

Last Update Submit

May 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Increase in Body Weight

    Increase in body weight as a marker of rehabilitation

    Up to three months during inpatient rehabilitation

Secondary Outcomes (8)

  • Metabolic recovery in patients with AN

    Up to three months during inpatient rehabilitation

  • Changes in ghrelin levels

    Up to three months during inpatient rehabilitation

  • Changes in blood metals and metalloids

    Up to three months during inpatient rehabilitation

  • Changes in leptin levels

    Up to three months during inpatient rehabilitation

  • Changes in IL-6 levels

    Up to three months during inpatient rehabilitation

  • +3 more secondary outcomes

Study Arms (1)

Anorexia Nervosa (AN)

Anorexia Nervosa patients hospitalized for rehabilitation

Other: Rehabilitation

Interventions

Hospitalized patients with AN under treatment for rehabilitation

Anorexia Nervosa (AN)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

13 Males and females with AN who are hospitalized for rehabilitation

You may qualify if:

  • Patients with Anorexia Nervosa according to the DSM-V (American Psychiatric Association, 2013)

You may not qualify if:

  • Antibiotic treatment before and during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaliora, Andriana C.

Athens, Attica, Greece

Location

Biospecimen

Retention: SAMPLES WITH DNA

Fecal samples are used to extract DNA for NGS

MeSH Terms

Conditions

Anorexia Nervosa

Interventions

Rehabilitation

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Andriana C. Kaliora

    Harokopio University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. in Human Nutrition and Foods

Study Record Dates

First Submitted

November 8, 2022

First Posted

November 25, 2022

Study Start

September 1, 2022

Primary Completion

October 24, 2023

Study Completion

December 24, 2023

Last Updated

May 20, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations